The interaction between signal regulatory protein alpha (SIRPα) and CD47: Structure, function, and therapeutic target

Annual Review of Immunology

Volumn 32, Issue , 2014, Pages 25-50

  Barclay, A Neil ^a   Van Den Berg, Timo K ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cancer; CD47; Inflammation; Paired receptor; Phagocytosis; SIRP

Indexed keywords

CD47 ANTIGEN; PEPTIDES AND PROTEINS; RITUXIMAB; SIGNAL REGULATORY PROTEIN ALPHA; UNCLASSIFIED DRUG;

AUTOIMMUNITY; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; DENDRITIC CELL; DRUG DELIVERY SYSTEM; GRAFT SURVIVAL; HEMATOLOGIC DISEASE; HOST CELL; HOST RESISTANCE; HUMAN; IMMUNOLOGICAL SYNAPSE; INFECTION; INFLAMMATION; NEOPLASM; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; T LYMPHOCYTE ACTIVATION; TUMOR XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; ANTIGENS, CD47; ANTIGENS, DIFFERENTIATION; AUTOIMMUNE DISEASES; DENDRITIC CELLS; HEMATOLOGIC DISEASES; HUMANS; IMMUNOLOGICAL SYNAPSES; MOLECULAR TARGETED THERAPY; MULTIGENE FAMILY; NEOPLASMS; PHAGOCYTOSIS; PROTEIN BINDING; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84893587799     PISSN: 07320582     EISSN: 15453278     Source Type: Book Series    
DOI: 10.1146/annurev-immunol-032713-120142     Document Type: Review

References (156)

1. Fujioka Y,Matozaki T,Noguchi T, Iwamatsu A, Yamao T, et al. 1996. A novel membrane glycoprotein, SHPS-1, that binds the SH2-domain-containing protein tyrosine phosphatase SHP-2 in response to mitogens and cell adhesion. Mol. Cell. Biol. 16:6887-99
2. Jiang P, Lagenaur CF, Narayanan V. 1999. Integrin-Associated protein is a ligand for the P84 neural adhesion molecule. J. Biol. Chem. 274:559-62
3. Seiffert M, Cant C, Chen Z, Rappold I, Brugger W, et al. 1999. Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47. Blood 94:3633-43
4. Vernon-Wilson EF, Kee WJ, Willis AC, Barclay AN, Simmons DL, Brown MH. 2000. CD47 is a ligand for rat macrophage membrane signal regulatory protein SIRP (OX41) and human SIRPα1. Eur. J. Immunol. 30:2130-37
5. Campbell IG, Freemont PS, FoulkesW, Trowsdale J. 1992. An ovarian tumormarker with homology to vaccinia virus contains an IgV-like region and multiple transmembrane domains. Cancer Res. 52:5416-20
6. Barclay AN, Brown MH. 2006. The SIRP family of receptors and immune regulation. Nat. Rev. Immunol. 6:457-64
7. Van den Berg TK, Van der Schoot CE. 2008. Innate immune 'self ' recognition: a role for CD47-SIRPα interactions in hematopoietic stem cell transplantation. Trends Immunol. 29:203-6
8. Mi ZP, Jiang P,WengWL, Lindberg FP, Narayanan V, Lagenaur CF. 2000. Expression of a synapseassociated membrane protein, P84/SHPS-1, and its ligand, IAP/CD47, in mouse retina. J. Comp. Neurol. 416:335-44
9. Umemori H, Sanes JR. 2008. Signal regulatory proteins (SIRPS) are secreted presynaptic organizing molecules. J. Biol. Chem. 283:34053-61
10. Van Beek EM, Cochrane F, Barclay AN, Van den Berg TK. 2005. Signal regulatory proteins in the immune system. J. Immunol. 175:7781-87
11. Stefanidakis M, Newton G, LeeWY, Parkos CA, Luscinskas FW. 2008. Endothelial CD47 interaction with SIRPγ is required for human T-cell transendothelial migration under shear flow conditions in vitro. Blood 112:1280-89
12. Alenghat FJ, Baca QJ, Rubin NT, Pao LI, Matozaki T, et al. 2012. Macrophages require Skap2 and Sirpαfor integrin-stimulated cytoskeletal rearrangement. J. Cell Sci. 125:5535-45
13. Piccio L, VermiW, Boles KS, Fuchs A, Strader CA, et al. 2005. Adhesion of human T cells to antigenpresenting cells through SIRPβ2-CD47 interaction costimulates T-cell proliferation. Blood 105:2421-27
14. Van den Berg TK, Van Beek EM, Buhring HJ, Colonna M, Hamaguchi M, et al. 2005. A nomenclature for signal regulatory protein family members. J. Immunol. 175:7788-89
15. Viertlboeck BC, Schmitt R, Gobel TW. 2006. The chicken immunoregulatory receptor families SIRP, TREM, and CMRF35/CD300L. Immunogenetics 58:180-90
16. Kaur S, Soto-Pantoja DR, Stein EV, Liu C, Elkahloun AG, et al. 2013. Thrombospondin-1 signaling through CD47 inhibits self-renewal by regulating c-Myc and other stem cell transcription factors. Sci. Rep. 3:1673
17. Csanyi G, Yao M, Rodriguez AI, Al Ghouleh I, Sharifi-Sanjani M, et al. 2012. Thrombospondin-1 regulates blood flow via CD47 receptor-mediated activation of NADPH oxidase 1. Arterioscler. Thromb. Vasc. Biol. 32:2966-73
18. Oldenborg P-A. 2013. CD47: a cell surface glycoprotein which regulates multiple functions of hematopoietic cells in health and disease. ISRN Hematol. 2013:614619
19. Soto-Pantoja DR, Stein EV, Rogers NM, Sharifi-Sanjani M, Isenberg JS, Roberts DD. 2013. Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47. Expert Opin. Ther. Targets 17:89-103
20. JanssenWJ, McPhillipsKA, DickinsonMG, Linderman DJ, Morimoto K, et al. 2008. Surfactant proteins A andDsuppress alveolar macrophage phagocytosis via interaction with SIRPα.Am. J. Respir. Crit.Care Med. 178:158-67
21. Fournier B, Andargachew R, Robin AZ, Laur O, Voelker DR, et al. 2012. Surfactant protein D (Sp-D) binds to membrane-proximal domain (D3) of signal regulatory protein α (SIRPα), a site distant from binding domain of CD47, while also binding to analogous region on signal regulatory proteinβ(SIRPβ). J. Biol. Chem. 287:19386-98
22. Adams S, Van der Laan LJ, Vernon-Wilson E, Renardel de Lavalette C, Dopp EA, et al. 1998. Signalregulatory protein is selectively expressed by myeloid and neuronal cells. J. Immunol. 161:1853-59
23. Veillette A, Thibaudeau E, Latour S. 1998. High expression of inhibitory receptor SHPS-1 and its association with protein-tyrosine phosphatase SHP-1 in macrophages. J. Biol. Chem. 273:22719-28
24. Milling S, Yrlid U, Cerovic V, MacPherson G. 2010. Subsets of migrating intestinal dendritic cells. Immunol. Rev. 234:259-67
25. Brooke G, Holbrook JD, Brown MH, Barclay AN. 2004. Human lymphocytes interact directly with CD47 through a novel member of the signal regulatory protein (SIRP) family. J. Immunol. 173:2562-70
26. Dietrich J, Cella M, Seiffert M, Buhring HJ, Colonna M. 2000. Cutting edge: signal-regulatory protein β1 is a DAP12-Associated activating receptor expressed in myeloid cells. J. Immunol. 164:9-12
27. Zhao XW, Van Beek EM, Schornagel K, Van der Maaden H, Van Houdt M, et al. 2011. CD47- signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction. Proc. Natl. Acad. Sci. USA 108:18342-47
28. Akkaya M, Barclay AN. 2013.Howdo pathogens drive the evolution of paired receptors? Eur. J. Immunol. 43:303-13
29. Carlyle JR, Mesci A, Fine JH, Chen P, Belanger S, et al. 2008. Evolution of the Ly49 and Nkrp1 recognition systems. Semin. Immunol. 20:321-30
30. Van VQ, Raymond M, Baba N, Rubio M, Wakahara K, et al. 2012. CD47high expression on CD4 effectors identifies functional long-lived memory T cell progenitors. J. Immunol. 188:4249-55
31. Jaiswal S, Jamieson CH, Pang WW, Park CY, ChaoMP, et al. 2009. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 138:271-85
32. Jaiswal S, ChaoMP, Majeti R, Weissman IL. 2010. Macrophages as mediators of tumor immunosurveillance. Trends Immunol. 31:212-19
33. Chao MP, Alizadeh AA, Tang C, Myklebust JH, Varghese B, et al. 2010. Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma. Cell 142:699-713
34. Majeti R, Chao MP, Alizadeh AA, PangWW,Jaiswal S, et al. 2009. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell 138:286-99
35. Kuriyama T, Takenaka K, Kohno K, Yamauchi T, Daitoku S, et al. 2012. Engulfment of hematopoietic stem cells caused by down-regulation of CD47 is critical in the pathogenesis of hemophagocytic lymphohistiocytosis. Blood 120:4058-67
36. HatherleyD,Graham SC, Harlos K, Stuart DI, Barclay AN. 2009. Structure of signal-regulatory protein α: a link to antigen receptor evolution. J. Biol. Chem. 284:26613-19
37. Nettleship JE, Ren J, Scott DJ, Rahman N, HatherleyD, et al. 2013. Crystal structure of signal regulatory protein gamma (SIRPγ) in complex with an antibody Fab fragment reveals the potential to form headto- head dimers. BMC Struct. Biol. 13:13
38. Hatherley D, Graham SC, Turner J, Harlos K, Stuart DI, Barclay AN. 2008. Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47. Mol. Cell 31:266-77
39. Hatherley D, Harlos K, Dunlop DC, Stuart DI, Barclay AN. 2007. The structure of the macrophage signal regulatory protein α(SIRPα) inhibitory receptor reveals a binding face reminiscent of that used by T cell receptors. J. Biol. Chem. 282:14567-75
40. Nakaishi A, Hirose M, YoshimuraM,Oneyama C, SaitoK, et al. 2008. Structural insight into the specific interaction between murine SHPS-1/SIRPαand its ligand CD47. J. Mol. Biol. 375:650-60
41. Van derMerwe PA, Davis SJ. 2003 Molecular interactions mediating T cell antigen recognition. Annu. Rev. Immunol. 21 659-84
42. Seiffert M, Brossart P, Cant C, Cella M, Colonna M, et al. 2001. Signal-regulatory protein α(SIRPα) but not SIRPβ is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34+CD38? hematopoietic cells. Blood 97:2741-49
43. Barclay AN, Hatherley D. 2008. The counterbalance theory for evolution and function of paired receptors. Immunity 29:675-78
44. Van den Berg TK, Yoder JA, Litman GW. 2004. On the origins of adaptive immunity: innate immune receptors join the tale. Trends Immunol. 25:11-16
45. Agrawal A, Eastman QM, Schatz DG. 1998. Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system. Nature 394:744-51
46. Abi-Rached L, Parham P. 2005. Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. J. Exp. Med. 201:1319-32
47. Takenaka K, Prasolava TK,Wang JC, Mortin-Toth SM, Khalouei S, et al. 2007. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat. Immunol. 8:1313-23
48. Cameron CM, Barrett JW,MannM, Lucas A, McFaddenG. 2005. Myxoma virusM128L is expressed as a cell surface CD47-like virulence factor that contributes to the downregulation ofmacrophage activation in vivo. Virology 337:55-67
49. Angus KL, Griffiths GM. 2013. Cell polarisation and the immunological synapse. Curr. Opin. Cell Biol. 25:85-91
50. Xie J, Tato CM, Davis MM. 2013. How the immune system talks to itself: the varied role of synapses. Immunol. Rev. 251:65-79
51. Hatherley D, Lea SM, Johnson S, Barclay AN. 2013. Structures of CD200/CD200 receptor family and implications for topology, regulation, and evolution. Structure 21:820-32
52. Tsai RK, Discher DE. 2008. Inhibition of "self " engulfment through deactivation of myosin-II at the phagocytic synapse between human cells. J. Cell Biol. 180:989-1003
53. Van Spriel AB, Leusen JH, Van Egmond M, Dijkman HB, Assmann KJ, et al. 2001. Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formation. Blood 97:2478-86
54. Takada T, Matozaki T, TakedaH, Fukunaga K,Noguchi T, et al. 1998. Roles of the complex formation of SHPS-1 with SHP-2 in insulin-stimulated mitogen-Activated protein kinase activation. J. Biol. Chem. 273:9234-42
55. Lorenz U. 2009. SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels. Immunol. Rev. 228:342-59
56. Van Beek EM, Zarate JA, Van Bruggen R, Schornagel K, Tool AT, et al. 2012. SIRPα controls the activity of the phagocyte NADPH oxidase by restricting the expression of gp91phox. Cell Rep. 2:748-55
57. Carter-Su C, Rui L, Stofega MR. 2000. SH2-B and SIRP: JAK2 binding proteins that modulate the actions of growth hormone. Recent Prog. Horm. Res. 55:293-311
58. Timms JF, Swanson KD, Marie-Cardine A, Raab M, Rudd CE, et al. 1999. SHPS-1 is a scaffold for assembling distinct adhesion-regulated multi-protein complexes in macrophages. Curr. Biol. 9:927-30
59. Johansen ML, Brown EJ. 2007. Dual regulation of SIRPα phosphorylation by integrins and CD47. J. Biol. Chem. 282:24219-30
60. BrownEJ, FrazierWA. 2001. Integrin-Associated protein (CD47) and its ligands. Trends Cell Biol. 11:130-35
61. de Vries HE, Hendriks JJ, Honing H, De Lavalette CR, Van der Pol SM, et al. 2002. Signal-regulatory protein α-CD47 interactions are required for the transmigration of monocytes across cerebral endothelium. J. Immunol. 168:5832-39
62. Liu Y, Buhring HJ, Zen K, Burst SL, Schnell FJ, et al. 2002. Signal regulatory protein (SIRPα), a cellular ligand for CD47, regulates neutrophil transmigration. J. Biol. Chem. 277:10028-36
63. Liu Y, Merlin D, Burst SL, Pochet M, Madara JL, Parkos CA. 2001. The role of CD47 in neutrophil transmigration. Increased rate of migration correlates with increased cell surface expression of CD47. J. Biol. Chem. 276:40156-66
64. Liu Y, O'Connor MB, Mandell KJ, Zen K, Ullrich A, et al. 2004. Peptide-mediated inhibition of neutrophil transmigration by blocking CD47 interactions with signal regulatory protein α. J. Immunol. 172:2578-85
65. Lindberg FP, BullardDC, Caver TE,Gresham HD, Beaudet AL, Brown EJ. 1996. Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice. Science 274:795-98
66. Bian Z, Guo Y, Luo Y, Tremblay A, Zhang X, et al. 2013. CD47 deficiency does not impede polymorphonuclear neutrophil transmigration but attenuates granulopoiesis at the postacute stage of colitis. J. Immunol. 190:411-17
67. Motegi S, Okazawa H, Ohnishi H, Sato R, Kaneko Y, et al. 2003. Role of the CD47-SHPS-1 system in regulation of cell migration. EMBO J. 22:2634-44
68. Tsuda M, Matozaki T, Fukunaga K, Fujioka Y, Imamoto A, et al. 1998. Integrin-mediated tyrosine phosphorylation of SHPS-1 and its association with SHP-2. Roles of Fak and Src family kinases. J. Biol. Chem. 273:13223-29
69. Deleted in proof
70. Oldenborg PA, Zheleznyak A, Fang YF, Lagenaur CF, GreshamHD, Lindberg FP. 2000. Role of CD47 as a marker of self on red blood cells. Science 288:2051-54
71. Okazawa H,Motegi S, Ohyama N, Ohnishi H, Tomizawa T, et al. 2005. Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system. J. Immunol. 174:2004-11
72. Oldenborg PA, GreshamHD, Lindberg FP. 2001. CD47-signal regulatory protein α(SIRPα) regulates Fcγand complement receptor-mediated phagocytosis. J. Exp. Med. 193:855-62
73. Matozaki T, Murata Y, Okazawa H, Ohnishi H. 2009. Functions and molecular mechanisms of the CD47-SIRPαsignalling pathway. Trends Cell Biol. 19:72-80
74. Burger P, Hilarius-Stokman P, de Korte D, Van den Berg TK, Van Bruggen R. 2012. CD47 functions as a molecular switch for erythrocyte phagocytosis. Blood 119:5512-21
75. Yamao T, Noguchi T, Takeuchi O, Nishiyama U,Morita H, et al. 2002. Negative regulation of platelet clearance and of the macrophage phagocytic response by the transmembrane glycoprotein SHPS-1. J. Biol. Chem. 277:39833-39
76. Wang H, Madariaga ML, Wang S, Van Rooijen N, Oldenborg PA, Yang YG. 2007. Lack of CD47 on nonhematopoietic cells induces split macrophage tolerance to CD47null cells. Proc. Natl. Acad. Sci. USA 104:13744-49
77. Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, et al. 2005. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436:709-13
78. Subramanian S, Boder ET, Discher DE. 2007. Phylogenetic divergence of CD47 interactions with human signal regulatory protein αreveals locus of species specificity. Implications for the binding site. J. Biol. Chem. 282:1805-18
79. Tsai RK, Rodriguez PL, Discher DE. 2010. Self inhibition of phagocytosis: the affinity of 'marker of self ' CD47 for SIRPα dictates potency of inhibition but only at low expression levels. Blood Cells Mol. Dis. 45:67-74
80. Theocharides AP, Jin L, Cheng PY, PrasolavaTK, Malko AV, et al. 2012. Disruption of SIRPαsignaling in macrophages eliminates human acute myeloid leukemia stem cells in xenografts. J. Exp.Med. 209:1883- 99
81. Legrand N, Huntington ND, Nagasawa M, Bakker AQ, Schotte R, et al. 2011. Functional CD47/signal regulatory protein alpha (SIRPα) interaction is required for optimal human T- and natural killer- (NK) cell homeostasis in vivo. Proc. Natl. Acad. Sci. USA 108:13224-29
82. Yamauchi T, Takenaka K, Urata S, Shima T, Kikushige Y, et al. 2013. Polymorphic Sirpa is the genetic determinant for NOD-basedmouse lines to achieve efficient human cell engraftment. Blood 121:1316-25
83. Strowig T, Rongvaux A, Rathinam C, Takizawa H, Borsotti C, et al. 2011. Transgenic expression of human signal regulatory protein alpha in Rag2 γc mice improves engraftment of human hematopoietic cells in humanized mice. Proc. Natl. Acad. Sci. USA 108:13218-23
84. Latour S, Tanaka H, Demeure C, Mateo V, Rubio M, et al. 2001. Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-α: downregulation of IL-12 responsiveness and inhibition of dendritic cell activation. J. Immunol. 167:2547-54
85. Raymond M, Rubio M, Fortin G, Shalaby KH, Hammad H, et al. 2009. Selective control of SIRP-α- positive airway dendritic cell trafficking through CD47 is critical for the development of TH2-mediated allergic inflammation. J. Allergy Clin. Immunol. 124:1333-42 e1
86. RaymondM, Van VQ, RubioM,Welzenbach K, SarfatiM. 2010. Targeting SIRP-αprotects from type 2-driven allergic airway inflammation. Eur. J. Immunol. 40:3510-18
87. Van VQ, Lesage S, Bouguermouh S, Gautier P, Rubio M, et al. 2006. Expression of the self-marker CD47 on dendritic cells governs their trafficking to secondary lymphoid organs. EMBO J. 25:5560-68
88. Yu X, Fukunaga A, Nagai H, Oniki S, Honma N, et al. 2006. Engagement of CD47 inhibits the contact hypersensitivity response via the suppression of motility and B7 expression by Langerhans cells. J. Invest. Dermatol. 126:797-807
89. Braun D, Galibert L, Nakajima T, Saito H, Quang VV, et al. 2006. Semimature stage: a checkpoint in a dendritic cell maturation program that allows for functional reversion after signal-regulatory protein-α ligation and maturation signals. J. Immunol. 177:8550-59
90. Fukunaga A, Nagai H, Noguchi T, Okazawa H, Matozaki T, et al. 2004. Src homology 2 domaincontaining protein tyrosine phosphatase substrate 1 regulates the migration of Langerhans cells from the epidermis to draining lymph nodes. J. Immunol. 172:4091-99
91. Motegi S, OkazawaH,Murata Y,Kanazawa Y, Saito Y, et al. 2008. Essential roles of SHPS-1 in induction of contact hypersensitivity of skin. Immunol. Lett. 121:52-60
92. Okajo J, Kaneko Y, Murata Y, Tomizawa T, Okuzawa C, et al. 2007. Regulation by Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 of alpha-galactosylceramide-induced antimetastatic activity and Th1 and Th2 responses of NKT cells. J. Immunol. 178:6164-72
93. Beattie L, SvenssonM, Bune A, Brown N, Maroof A, et al. 2010. Leishmania donovani-induced expression of signal regulatory protein αon Kupffer cells enhances hepatic invariant NKT-cell activation. Eur. J. Immunol. 40:117-23
94. Morimoto N, Murata Y, Motegi S, Suzue K, Saito Y, et al. 2010. Requirement of SIRPαfor protective immunity against Leishmania major. Biochem. Biophys. Res. Commun. 401:385-89
95. Bian Z,GuoY,HaB,Zen K, LiuY. 2012. Regulation of the inflammatory response: enhancing neutrophil infiltration under chronic inflammatory conditions. J. Immunol. 188:844-53
96. Fortin G, Raymond M, Van VQ, Rubio M, Gautier P, et al. 2009. A role for CD47 in the development of experimental colitis mediated by SIRPα+CD103? dendritic cells. J. Exp. Med. 206:1995-2011
97. Tomizawa T, Kaneko Y, Kaneko Y, Saito Y, Ohnishi H, et al. 2007. Resistance to experimental autoimmune encephalomyelitis and impaired T cell priming by dendritic cells in Src homology 2 domaincontaining protein tyrosine phosphatase substrate-1 mutant mice. J. Immunol. 179:869-77
98. Li LX, Atif SM, Schmiel SE, Lee SJ, McSorley SJ. 2012. Increased susceptibility to Salmonella infection in signal regulatory protein α-deficient mice. J. Immunol. 189:2537-44
99. Tseng D, Volkmer J-P, Willingham SB, Contreras-Trujillo H, Fathman JW, et al. 2013. Anti-CD47 antibody-mediated phagocytosis of cancer bymacrophages primes an effective antitumor T-cell response. Proc. Natl. Acad. Sci. USA 110:11103-8
100. Sato-Hashimoto M, Saito Y, Ohnishi H, Iwamura H, Kanazawa Y, et al. 2011. Signal regulatory protein αregulates the homeostasis of T lymphocytes in the spleen. J. Immunol. 187:291-97
101. Weiskopf K, Ring AM, Ho CC, Volkmer J-P, Levin AM, et al. 2013. Engineered SIRPαvariants as immunotherapeutic adjuvants to anticancer antibodies. Science 341:88-91
102. Han MH, Lundgren DH, Jaiswal S, Chao M, Graham KL, et al. 2012. Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice. J. Exp. Med. 209:1325-34
103. Okuzawa C, Kaneko Y,Murata Y,Miyake A, Saito Y, et al. 2008. Resistance to collagen-induced arthritis in SHPS-1 mutant mice. Biochem. Biophys. Res. Commun. 371:561-66
104. Tanaka K, Horikawa T, Suzuki S, Kitaura K, Watanabe J, et al. 2008. Inhibition of Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 reduces the severity of collagen-induced arthritis. J. Rheumatol. 35:2316-24
105. Verdrengh M, Lindberg FP, Ryden C, Tarkowski A. 1999. Integrin-Associated protein (IAP)-deficient mice are less susceptible to developing Staphylococcus aureus-induced arthritis. Microbes Infect. 1:745-51
106. Baba N, Van VQ, Wakahara K, Rubio M, Fortin G, et al. 2013. CD47 fusion protein targets CD172a+ cells in Crohn's disease and dampens the production of IL-1βand TNF. J. Exp. Med. 210:1251-63
107. Gitik M, Liraz-Zaltsman S, Oldenborg P-A, Reichert F, Rotshenker S. 2011. Myelin down-regulates myelin phagocytosis by microglia and macrophages through interactions between CD47 on myelin and SIRPα(signal regulatory protein-α) on phagocytes. J. Neuroinflamm. 8:24
108. Kobayashi M, Ohnishi H, Okazawa H, Murata Y, Hayashi Y, et al. 2008. Expression of Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 in pancreatic β-cells and its role in promotion of insulin secretion and protection against diabetes. Endocrinology 149:5662-69
109. Maile LA,DeMambro VE, Wai C, Lotinun S, Aday AW, et al. 2011. An essential role for the association of CD47 to SHPS-1 in skeletal remodeling. J. Bone Miner. Res. 26:2068-81
110. Oldenborg P-A, Gresham HD, Chen Y, Izui S, Lindberg FP. 2002. Lethal autoimmune hemolytic anemia in CD47-deficient nonobese diabetic (NOD) mice. Blood 99:3500-4
111. Olsson M, Bruhns P, FrazierWA, Ravetch JV, Oldenborg P-A. 2005. Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia. Blood 105:3577-82
112. Ahrens N, Pagenkopf C, Kiesewetter H, Salama A. 2006. CD47 is expressed at normal levels in patients with autoimmune haemolytic anaemia and/or immune thrombocytopenia. Transfus. Med. 16:397-402
113. Barros MM, Yamamoto M, Figueiredo MS, Cancado R, Kimura EY, et al. 2009. Expression levels of CD47, CD35, CD55, and CD59 on red blood cells and signal-regulatory protein-α,β on monocytes from patients with warm autoimmune hemolytic anemia. Transfusion 49:154-60
114. Catani L, Sollazzo D, Ricci F, Polverelli N, Palandri F, et al. 2011. The CD47 pathway is deregulated in human immune thrombocytopenia. Exp. Hematol. 39:486-94
115. Jackson A, Nanton MR, O'Donnell H, Akue AD, McSorley SJ. 2010. Innate immune activation during Salmonella infection initiates extramedullary erythropoiesis and splenomegaly. J. Immunol. 185:6198-204
116. Nairz M, Schroll A, Moschen AR, Sonnweber T, Theurl M, et al. 2011. Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-κB-inducible immune pathways. Immunity 34:61-74
117. Baral P, Utaisincharoen P. 2012. Involvement of signal regulatory protein alpha, a negative regulator of Toll-like receptor signaling, in impairing the MyD88-independent pathway and intracellular killing of Burkholderia pseudomallei-infected mouse macrophages. Infect. Immun. 80:4223-31
118. Dong LW, Kong XN, Yan HX, Yu LX, Chen L, et al. 2008. Signal regulatory protein alpha negatively regulates bothTLR3 and cytoplasmic pathways in type I interferon induction. Mol. Immunol. 45:3025-35
119. Kong XN, Yan HX, Chen L, Dong LW, Yang W, et al. 2007. LPS-induced down-regulation of signal regulatory protein αcontributes to innate immune activation in macrophages. J. Exp.Med. 204:2719-31
120. Stacey KJ, Sester DP, Sweet MJ,Hume DA. 2000. Macrophage activation by immunostimulatoryDNA. Curr. Top. Microbiol. Immunol. 247:41-58
121. Su X, Johansen M, Looney MR, Brown EJ, Matthay MA. 2008. CD47 deficiency protects mice from lipopolysaccharide-induced acute lung injury and Escherichia coli pneumonia. J. Immunol. 180:6947-53
122. Ide K, Wang H, Tahara H, Liu J, Wang X, et al. 2007. Role for CD47-SIRPα signaling in xenograft rejection by macrophages. Proc. Natl. Acad. Sci. USA 104:5062-66
123. Wang H, VerHalen J, Madariaga ML, Xiang S, Wang S, et al. 2007. Attenuation of phagocytosis of xenogeneic cells by manipulating CD47. Blood 109:836-42
124. Wang C, Wang H, IdeK,Wang Y, Van RooijenN, et al. 2011. HumanCD47 expression permits survival of porcine cells in immunodeficient mice that express SIRPαcapable of binding to human CD47. Cell Transplant. 20:1915-20
125. Galili U, Rachmilewitz EA, Peleg A, Flechner I. 1984. A unique natural human IgG antibody with anti-α-galactosyl specificity. J. Exp. Med. 160:1519-31
126. Navarro-Alvarez N, Yang YG. 2013. Lack of CD47 on donor hepatocytes promotes innate immune cell activation and graft loss: a potential barrier to hepatocyte xenotransplantation. Cell Transplant. In press. doi: 10.3727/096368913X663604
127. Waern JM, Yuan Q, Rudrich U, Becker PD, Schulze K, et al. 2012. Ectopic expression of murine CD47 minimizes macrophage rejection of human hepatocyte xenografts in immunodeficient mice. Hepatology 56:1479-88
128. Wang Y, Wang H, Wang S, Fu Y, Yang YG. 2010. Survival and function of CD47-deficient thymic grafts in mice. Xenotransplantation 17:160-65
129. Wang H,WuX, Wang Y, Oldenborg P-A, Yang YG. 2010. CD47 is required for suppression of allograft rejection by donor-specific transfusion. J. Immunol. 184:3401-7
130. Chao MP, Alizadeh AA, Tang C, Jan M, Weissman-Tsukamoto R, et al. 2011. Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia. Cancer Res. 71:1374-84
131. Chao MP, Jaiswal S,Weissman-Tsukamoto R, Alizadeh AA, Gentles AJ, et al. 2010. Calreticulin is the dominant pro-phagocytic signal onmultiple human cancers and is counterbalanced by CD47. Sci. Transl. Med. 2:63ra94
132. Chao MP, Tang C, Pachynski RK, Chin R, Majeti R, Weissman IL. 2011. Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy. Blood 118:4890-901
133. Spaargaren M. 2011. Lymphoma spread? Target CD47-SIRPα! Blood 118:4762-64
134. Willingham SB, Volkmer JP, Gentles AJ, Sahoo D, Dalerba P, et al. 2012. The CD47-signal regulatory protein alpha (SIRPα) interaction is a therapeutic target for human solid tumors. Proc. Natl. Acad. Sci. USA 109:6662-67
135. Soto-Pantoja DR, Miller TW, Frazier WA, Roberts DD. 2012. Inhibitory signaling through signal regulatory protein-αis not sufficient to explain the antitumor activities of CD47 antibodies. Proc. Natl. Acad. Sci. USA 109:E2842
136. Zhao XW, Matlung HL, Kuijpers TW, Van den Berg TK. 2012. On the mechanism of CD47 targeting in cancer. Proc. Natl. Acad. Sci. USA 109:E2843
137. Chao MP, Weissman IL, Majeti R. 2012. The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications. Curr. Opin. Immunol. 24:225-32
138. Zhao XW, Kuijpers TW, Van den Berg TK. 2012. Is targeting of CD47-SIRPα enough for treating hematopoietic malignancy? Blood 119:4333-34
139. Kim MJ, Lee JC, Lee JJ, Kim S, Lee SG, et al. 2008. Association ofCD47with natural killer cell-mediated cytotoxicity of head-And-neck squamous cell carcinoma lines. Tumour Biol. 29:28-34
140. Sagawa M, Shimizu T, Fukushima N, Kinoshita Y, Ohizumi I, et al. 2011. A new disulfide-linked dimer of a single-chain antibody fragment against human CD47 induces apoptosis in lymphoid malignant cells via the hypoxia inducible factor-1αpathway. Cancer Sci. 102:1208-15
141. Uno S,Kinoshita Y, Azuma Y,Tsunenari T, Yoshimura Y, et al. 2007. Antitumor activity of a monoclonal antibody against CD47 in xenograft models of human leukemia. Oncol. Rep. 17:1189-94
142. Irandoust M, Alvarez Zarate J, Hubeek I, Van Beek EM, Schornagel K, et al. 2013. Engagement of SIRPαinhibits growth and induces programmed cell death in acute myeloid leukemia cells. PLoS ONE 8:e52143
143. Wang Y, Xu Z, Guo S, Zhang L, Sharma A, et al. 2013. Intravenous delivery of siRNA targeting CD47 effectively inhibits melanoma tumor growth and lung metastasis. Mol. Ther. 21:1919-29
144. Rodriguez PL, Harada T, Christian DA, Pantano DA, Tsai RK, Discher DE. 2013. Minimal "Self " peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles. Science 339:971-75
145. Hu C-MJ, Fang RH, Luk BT, Chen KN, Carpenter C, et al. 2013. 'Marker-of-self ' functionalization of nanoscale particles through a top-down cellular membrane coating approach. Nanoscale 5:2664-68
146. Rebres RA, Kajihara K, Brown EJ. 2005. Novel CD47-dependent intercellular adhesion modulates cell migration. J. Cell. Physiol. 205:182-93
147. Eck MJ, Pluskey S, Trub T, Harrison SC, Shoelson SE. 1996. Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2. Nature 379:277-80
148. Lanier LL. 2001. Face off-The interplay between activating and inhibitory immune receptors. Curr. Opin. Immunol. 13:326-31
149. Yamada E, McVicar DW. 2008. Paired receptor systems of the innate immune system. Curr. Protoc. Immunol. A.1X.1-25
150. Kuroki K, Furukawa A, Maenaka K. 2012. Molecular recognition of paired receptors in the immune system. Front. Microbiol. 3:429
151. Coles SJ, Hills RK, Wang EC, Burnett AK, Man S, et al. 2012. Expression of CD200 on AML blasts directly suppresses memory T-cell function. Leukemia 26:2148-51
152. Kretz-Rommel A, Qin F, Dakappagari N, Ravey EP, McWhirter J, et al. 2007. CD200 expression on tumor cells suppresses antitumor immunity: new approaches to cancer immunotherapy. J. Immunol. 178:5595-605
153. Rygiel TP, Meyaard L. 2012. CD200R signaling in tumor tolerance and inflammation: a tricky balance. Curr. Opin. Immunol. 24:233-38
154. Zhang L, Stanford M, Liu J, Barrett C, Jiang L, et al. 2009. Inhibition of macrophage activation by the myxoma virus M141 protein (vCD200). J. Virol. 83:9602-7
155. Spriggs MK. 1996. One step ahead of the game: viral immunomodulatorymolecules. Annu. Rev. Immunol. 14:101-30
156. Inagaki K, Yamao T, Noguchi T, Matozaki T, Fukunaga K, et al. 2000. SHPS-1 regulates integrinmediated cytoskeletal reorganization and cell motility. EMBO J. 19:6721-31